Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy
2009; Lippincott Williams & Wilkins; Volume: 24; Issue: 1 Linguagem: Inglês
10.1097/qad.0b013e32832e5303
ISSN1473-5571
AutoresRoger Paredes, Irene H. Cheng, Daniel R. Kuritzkes, Ruth Tuomala,
Tópico(s)HIV Research and Treatment
ResumoPregnancy-limited antiretroviral therapy (PLAT) drastically reduces HIV-1 transmission to the newborn, but may select for antiretroviral drug resistance mutations in mothers.
Referência(s)